- $2.22bn
- $2.45bn
- $727.33m
NeoGenomics falls on quarterly sales miss
Neogenomics Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Neogenomics Inc Reaffirms Full-Year 2025 Guidance
U.S. STOCKS ON THE MOVE-Wolfspeed, Netflix, Spotify
U.S. STOCKS ON THE MOVE-BlackRock, WEX, Big banks
U.S. STOCKS ON THE MOVE-Citigroup, Goldman Sachs, BlackRock
NeoGenomics rises on better-than-expected 2025 revenue forecast
Brief: Adaptive Biotechnologies Corp And Neogenomics Announce Strategic Collaboration
U.S. RESEARCH ROUNDUP- Constellation Brands, Merck, WD-40
Brief: NeoGenomics Announces Chief Executive Officer Succession
Brief: Felicia Williams Joins NeoGenomics Board Of Directors
Neogenomics Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Neogenomics Reports Third Quarter 2024 Results
Brief: Neogenomics Receives New York State Approval For Neo Comprehensive Solid Tumor Test
Neogenomics Inc expected to post breakeven results a share - Earnings Preview
Akili rises on plans to evaluate alternatives, reduce workforce
Neogenomics Inc reports results for the quarter ended in March - Earnings Summary
Neogenomics Inc expected to post a loss of 5 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Elf Beauty, Moderna, Zscaler